TO REGISTER: Scroll down and select the Webinar component
TO VIEW OTHER WEBINARS IN THIS SERIES: Click Here
Webinar 5 of 6 in the 2021 ASDS Diversity, Equity, Inclusion series
Jeanine Downie, MD and Sara Hogan, MD
Vivian Bucay, MD; Cheryl Burgess, MD; Seemal Desai, MD; Corey Hartman, MD; Vladimir Paul-Blanc; Douglas Wu, MD
Live webinar on Thursday, October 21, 7:30 pm CDT. This session features experienced skin of color dermatologists who are active in clinical trials research for the development of injectables, medications, devices, laser and light-based modalities. The issue of race in medicine influences and informs all clinical research trials. Historically, this has resulted in the underrepresentation of patients with skin of color with regard to cosmetic injectables and devices. Such underrepresentation has significant implications for clinical practice. This discussion will explore opportunities for industry to embrace diversity in their clinical trials as a way to become more inclusive and increase their own profitability.
At the conclusion of this activity, participants should be able to:
- Describe the clinical trials process for cosmetic injectables and devices.
- Discuss why skin of color patients historically have not been properly
recruited and retained for medication, cosmetic injectable, and laser and
light-based device clinical trials.
- Recognize opportunities for social accountability and future profitability for
industry and companies that include skin of color patients in clinical trials.
CME: 1.00 AMA PRA Category 1 Credit™
To obtain CME credit and download your CME certificate you will need to view the webinar and complete the attendee evaluation. Select the certificate for the format you completed, either the live webinar or on-demand.
We gratefully acknowledge Allergan, La Roche-Posay and Merz for their generous support of this educational activity.
The American Society for Dermatologic Surgery (ASDS) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. ASDS designates this activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.